We are united in our responsibility to create healthier futures.  Innomar Strategies (a part of Cencora) offers expertise in all areas of Regulatory Affairs, Quality Assurance and Drug Safety services to the pharmaceutical, biotechnology, natural health product and cosmetic industries at each stage of the product lifecycle. Innomar supports a wide variety of therapeutic areas such as gastrointestinal, CNS, ophthalmology, cardiovascular, biosimilars, rare disease, oncology as well as medical devices, with submissions to Health Canada, the FDA and other quasi regulatory bodies. Innomar is the leading specialty service provider in the Canadian healthcare market. Regulatory and market access strategic consulting, quality assurance, safety, patient support programs, nursing, clinical services, and specialty pharmacy and logistics are just a few of our key services as part of our commitment to comprehensive solution delivery for our clients.  We work closely with manufacturers, healthcare providers, and payers to ensure patients have consistent and reliable access to specialty medication.  Visit us at www.innomar-strategies.com.